Tenderwize
Back to tender search

Open house drug discount agreements Safinamide, ATC N04BD03

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 03, 2028 · 564 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Safinamid, ATC N04BD03

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

No guaranteed volume or minimum revenue. The agreement may be superseded by other discount contracts, leading to early...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Non-exclusive discount agreements for the active substance Safinamide (ATC N04BD03) under § 130a Abs. 8 SGB V.
  • Contract duration: 24 months (01.05.2026 – 30.04.2028).
Show full summary

This is an open-house model (not a standard procurement procedure) by AOK Bayern for non-exclusive discount agreements on the active substance Safinamide (ATC N04BD03). Any interested pharmaceutical company that meets the eligibility criteria can conclude an identical, non-negotiable discount agreement. The contract runs from 01.05.2026 to 30.04.2028, and new contracts can be concluded at any time until 03.03.2028. The agreement automatically terminates if a nationwide or region-specific discount contract for the same substance comes into effect. No estimated value is provided, and no award criteria apply as all qualified companies are accepted.

Risks

No guaranteed volume or minimum revenue. The agreement may be superseded by other discount contracts, leading to early...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company.

Administrative

  • Submit a signed declaration of reliability.
  • Submit signed contract and annex ("Festlegung der vertragsgegenständlichen Arzneimittel").

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria (open-house model). All eligible companies are accepted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house drug discount agreements Safinamide, ATC N04BD03

Non-exclusive discount agreements for Safinamide (ATC N04BD03) with AOK Bayern. Open to all pharmaceutical companies meeting eligibility. Contract period: 01.05.2026 - 30.04.2028. Early termination possible with one month notice. Automatically void if other discount contracts for the same substance become effective.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Apr 2026 - Apr 2028

Category

Pharmaceutical products

Award Criteria

No award criteria (open-house model). All eligible companies are accepted.

Procurement Details

Publication date
15 Mar 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
179421-2026

Documents (2)

Similar tenders